Author for correspondence: Su Qian, Department of Metabolic Disorders, Merck Research Laboratories, P.O. Box 2000, RY80M-213, Rahway, NJ 07065, USA (fax 732-594-6708, e-mail [email protected]).

Read the full text

About

PDF

Tools

Share a link

Email
Wechat
Bluesky

Abstract

Abstract: Cytosolic malic enzyme (ME-1) is a nicotinamide adenine dinucleotide phosphate (NADP)-dependent enzyme that generates NADPH. The activity of this enzyme, the reversible oxidative decarboxylation of malate to yield pyruvate, links glycolytic pathway to citric acid cycle. The high level of ME-1 expression in liver, and its involvement in NADPH production, suggests reduced ME-1 activity might compromise hepatic production of reduced glutathione (GSH) by the NADPH-dependent enzyme glutathione reductase, and hence affect xenobiotic detoxification. The role of ME-1 in liver detoxification was evaluated in Mod1 deficient mice (mod1^−/–) by evaluating their sensitivity to acetaminophen-induced liver injury. The results show that mod1^−/– mice are not more sensitive to acetaminophen hepato-toxicity. Although GSH levels were initially depleted more in the mod1^−/– liver than in wild-type controls, the GSH levels recovered quickly. In conclusion, our data indicate that ME-1 deficiency does not adversely affect GSH-dependent detoxification.

References

1 Frenkel R. Regulation and physiological functions of malic enzymes. Curr Top Cell Regul 1975; 9: 157–81.
10.1016/B978-0-12-152809-6.50012-3
CAS PubMed Google Scholar
2 Wise EM, Ball EG. Malic enzyme and lipogenesis. Proc Natl Acad Sci USA 1964; 52: 1255–63.
10.1073/pnas.52.5.1255
CAS PubMed Web of Science® Google Scholar
3 Zelewski M, Swierczynski J. Malic enzyme in human liver, intracellular distribution, purification and properties of cytosolic isozyme. Eur J Biochem 1991; 201: 39–345.
10.1111/j.1432-1033.1991.tb16291.x
Web of Science® Google Scholar
4 Fitch WM, Chaikoff IL. Extent and patterns of adaptation of enzyme activities in livers of normal rats fed diets high in glucose and fructose. J Biol Chem 1960; 35: 554–7.
Google Scholar
5 Gayle Crozier G, Brigitte Bois-Joyeux B, Marc Chanez M, Jean Girard J, Peret J. Metabolic effects induced by long-term feeding of medium-chain triglycerides in the rat. Metabolism 1987; 36: 807–14.
10.1016/0026-0495(87)90122-3
PubMed Web of Science® Google Scholar
6 Van Schothorst EM, Keijer J, Pennings JL, Opperhuizen A, Van Den Brom CE, Kohl T et al . Adipose gene expression response of lean and obese mice to short-term dietary restriction. Obesity 2006; 14: 974–9.
10.1038/oby.2006.111
CAS PubMed Web of Science® Google Scholar
7 Yen TT, Greenberg MM, Yu PL, Pearson DV. An analysis of the relationships among obesity, plasma insulin and hepatic lipogenic enzymes in ‘viable yellow obese’ mice (Avy/a). Horm Metab Res 1976; 8: 159–66.
10.1055/s-0028-1093672
CAS PubMed Web of Science® Google Scholar
8 Huupponen R, Karvonen I, Sotaniemi E. Activity of hepatic glucose phosphorylating and NADPH generating enzymes in Zucker rats. Diabetes Res 1989; 10: 143–6.
CAS PubMed Web of Science® Google Scholar
9 Kam PL, Lin CC, Li JC, Meng CL, Chang GG. High malic enzyme activity in tumor cells and its cross-reaction with anti-pigeon liver malic enzyme serum. Mol Cell Biochem 1988; 79: 171–9.
10.1007/BF02424560
CAS PubMed Web of Science® Google Scholar
10 Loeber G, Dworkin MB, Infante A, Ahorn H. Characterization of cytosolic malic enzyme in human tumor cells. FEBS Lett 1994; 344: 181–6.
10.1016/0014-5793(94)00386-6
CAS PubMed Web of Science® Google Scholar
11 Ayala A, F-Lobato M, Machado A. Malic enzyme levels are increased by the activation of NADPH-consuming pathways: detoxification process. FEBS Lett 1986; 202: 102–6.
10.1016/0014-5793(86)80657-3
CAS PubMed Web of Science® Google Scholar
12 Lee CY, Lee SM, Lewis S, Johnson FM. Identification and biochemical analysis of mouse mutants deficient in cytoplasmic malic enzyme. Biochemistry 1980; 19: 5098–103.
10.1021/bi00563a025
CAS PubMed Web of Science® Google Scholar
13 Brown ML, Wise LS, Rubin CS. The molecular basis for a cytosolic malic enzyme deficient mutation. J Biol Chem 1988; 263: 4494–9.
CAS PubMed Web of Science® Google Scholar
14 Dahlin DC, Miwa GT, Lu AY, Nelson SD. N-acetyl-p- benzoquinone imine: acytochrome P-450-mediated oxidation product of acetaminophen. Proc Natl Acad Sci USA 1984; 81: 1327–31.
10.1073/pnas.81.5.1327
CAS PubMed Web of Science® Google Scholar
15 James PL, Mayeux PR, Hinson JA. Acetaminophen-induced hepatoxicity. Drug Metab Dispos 2003; 31: 1499–506.
10.1124/dmd.31.12.1499
CAS PubMed Web of Science® Google Scholar
16 Rashed MS, Myers TG, Nelson SD. Hepatic protein aryltion, glutathione depletion, and metabolite profiles of acetaminophen and a non-hepatotoxic regioisomer, 3′-hydroxyacetanilide, in the mouse. Drug Metab Dispos 1990; 18: 765–70.
CAS PubMed Web of Science® Google Scholar
17 Velasco P, Barcia R, Ibarguren I, Sieiro AM, Ramos-Martinez JI. Purification, characterization and kinetic mechanism of glucose-6-phosphate dehydrogenase from mouse liver. Int J Biochem 1994; 26: 195–200.
10.1016/0020-711X(94)90145-7
CAS PubMed Web of Science® Google Scholar
18 Bradford MM. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976; 72: 248–54.
10.1016/0003-2697(76)90527-3
CAS PubMed Web of Science® Google Scholar
19 Schadt EE, Lamb J, Yang X, Zhu J, Edwards S, GuhaThakurta D et al . An integrative genomics approach to infer causal associations between gene expression and disease. Nat Genet 2005; 37: 710–7.
10.1038/ng1589
CAS PubMed Web of Science® Google Scholar
20 Geer BW, Krochko D, Williamson JH. Ontogeny, cell distribution, and the physiological role of NADP-malic enzyme in Drosophila melanogaster. Biochem Genet 1979; 17: 867–79.
10.1007/BF00504309
CAS PubMed Web of Science® Google Scholar
21 Geer BW, Lindel DL, Lindel DM. Relationship of the oxidative pentose shunt pathway to lipid synthesis in Drosophila melanogaster. Biochem Genet 1979; 17: 881–95.
10.1007/BF00504310
CAS PubMed Web of Science® Google Scholar
22 Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005; 115: 1111–9.
10.1172/JCI25102
CAS PubMed Web of Science® Google Scholar
23 Blazka ME, Elwell MR, Holladay SD, Wilson RE, Luster MI. Histopathology of acetaminophen-induced liver changes: role of interleukin 1 alpha and tumor necrosis factor alpha. Toxicol Pathol 1996; 24: 181–9.
10.1177/019262339602400206
CAS PubMed Web of Science® Google Scholar
24 Ishida Y, Kondo T, Ohshima T, Fujiwara H, Iwakura Y, Mukaida N. A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J 2002; 16: 1227–36.
10.1096/fj.02-0046com
CAS PubMed Web of Science® Google Scholar
25 Bourdi M, Masubuchi Y, Reilly T, Amouzadeh HR, Martin J, George JW et al . Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 2002; 35: 289–98.
10.1053/jhep.2002.30956
CAS PubMed Web of Science® Google Scholar
26 Zhang YJ, Wang Z, Sprous D, Nabioullin R. In silico design and synthesis of piperazine-1-pyrrolidine-2,5-dione scafford-based novel malic enzyme inhibitors. Bioorg Med Chem Lett 2006; 16: 525–8.
10.1016/j.bmcl.2005.10.065
CAS PubMed Web of Science® Google Scholar

Citing Literature

Volume103, Issue1

July 2008

Pages 36-42

Deficiency in Cytosolic Malic Enzyme Does Not Increase Acetaminophen-Induced Hepato-Toxicity

Abstract

References

Citing Literature

References

Information

About Wiley Online Library

Help & Support

Opportunities

Connect with Wiley

Deficiency in Cytosolic Malic Enzyme Does Not Increase Acetaminophen-Induced Hepato-Toxicity

Abstract

References

Citing Literature

References

Related

Information